StockData
CME Group Inc. logo

CME Group Inc. (CME) stock analysis

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/3020% above fair value
$315.50−0.37 (-0.12%)

Close on Nov 12, 2026Market cap $112.93BP/E 25.9Yield 1.58%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth1Performance2Health5Dividend1

Mixed9 of 30 checks passed

CME passes 9 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
1/6
Past performance
2/6
Financial health
5/6
Dividend
1/6

What stands out

  • Return on capital over 10%

    Return on invested capital was 14.1%, above the 10% that usually covers the cost of capital.

  • No debt

    CME has no borrowings on its latest balance sheet.

  • Earnings grew over 5 years

    Net income grew 14.1% a year on average over the last five fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 14.7% a year over the last three fiscal years.

What to watch

  • Margin of safety under 20%

    The price is 20.2% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $315.87 is above our fair value estimate of $262.74.

  • Revenue growing under 10% a year

    Revenue grew 9.1% a year over the last three fiscal years, short of the 10% we look for.

  • Elevated bankruptcy risk

    The Altman Z-score is 0.59; above 3 is the safe zone and below 1.8 the distress zone.

Valuation0/6
  • P/E above its 5-year median

    CME's P/E of 25.9 is above its own 5-year median of 25.2.

  • P/E above the industry

    CME's P/E of 25.9 is above the Security & commodity brokers, dealers, exchanges & services median of 25.3.

  • EV/EBITDA above its 5-year median

    CME's EV/EBITDA of 24.2 is above its 5-year median of 22.2.

  • P/B above the industry

    CME's price-to-book of 4.26 is above the Security & commodity brokers, dealers, exchanges & services median of 4.26.

  • Trading above fair value

    The share price of $315.87 is above our fair value estimate of $262.74.

  • Margin of safety under 20%

    The price is 20.2% above fair value, so there is no margin of safety.

Growth1/6
  • Revenue growing under 10% a year

    Revenue grew 9.1% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 14.7% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew 9.0% over the last twelve months; the Security & commodity brokers, dealers, exchanges & services median is 14.4%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin trend

    This company does not report gross profit.

Past performance2/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on capital over 10%

    Return on invested capital was 14.1%, above the 10% that usually covers the cost of capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings grew over 5 years

    Net income grew 14.1% a year on average over the last five fiscal years.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin against the industry

    Needs revenue and net income.

Financial health5/6
  • No debt

    CME has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term assets cover short-term debts

    Current assets are 1.02 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is 0.59; above 3 is the safe zone and below 1.8 the distress zone.

Dividend1/6
  • Pays a dividend

    CME paid dividends worth 3.6% of the share price over the last twelve months.

  • Yield below Treasuries

    The 3.6% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; CME yields 3.6%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Earnings cover

    Needs dividends paid and net income.

  • Not covered by free cash flow

    Dividends take 94.3% of free cash flow.

Scores of similar companies

Our estimate per share

$262.74

The share price is 20% above this estimate.

20%+ below
Near fair value
20%+ above
$315.87Price$262.74Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E25.2×25.2×25.3×$307.5640%
EV/EBITDA20.0×22.2×17.8×$262.8135%
P/B3.6×2.9×4.3×$265.9810%
Earnings power7.4% cost of equity––$140.9215%
Fair value$262.74100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 25.2
  • Security & commodity brokers, dealers, exchanges & services median 25.3

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$593.07M
Value traded per 1% price move
$465.14M

Downside

Medium risk

Typical loss in a bad month
16.7%
Volatility (annualized)
25%
Sharpe ratio, 1 year
0.38
Beta to the S&P 500 (5Y)
0.36

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Operating margin

64.9%+10.9 pts over 5 years

Net margin

62.5%+19.3 pts over 5 years

See a number that looks wrong?